Five execs: Here are the greatest challenges for Coloplast
Coloplast wants to generate revenue of up to DKK 20.5 billion in five years, but there are bound to be obstacles along the way. Medwatch has asked five executives from the medtech group where they see the greatest challenges arising within their respective areas.
by Leonora Beck
In five years, Coloplast’s already impressive profit margin of just shy of 32% could be hiked up to 39% if the Danish medtech group comes in at the high end of its new long-term guidance.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Coloplast set new long-term goals
For abonnenter
Coloplast’s Head of Media resigns
For abonnenter
